TCG Crossover Management, LLC
- SEC CIK
- 0001839948
- Latest filing
- Aug 14, 2026
Holdings in Q1 2022
Holdings as of Mar 31, 2022, filed May 16, 2022. Long positions only; changes compare share counts with Q4 2021.
- Positions
- 20
- +5 vs. Q4 2021
- Portfolio value
- $249.1M
- +$35.5M (+16.6%) vs. Q4 2021
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| ISEEIVERIC bio, Inc. | COM | 2,516,920 | $42.4M | 17.0% | +775,692+44.5% | Added | History |
| VRDNViridian Therapeutics, Inc. | COM | 1,314,000 | $24.3M | 9.8% | 00.0% | Unchanged | History |
| COGTCogent Biosciences, Inc. | COM | 2,981,042 | $22.3M | 9.0% | +231,005+8.4% | Added | History |
| ACRSAclaris Therapeutics, Inc. | COM | 1,144,939 | $19.7M | 7.9% | +62,726+5.8% | Added | History |
| GERNGeron Corp | COM | 14,285,715 | $19.4M | 7.8% | +14,285,715 | New | History |
| CBAYCymaBay Therapeutics, Inc. | COM | 5,905,400 | $18.4M | 7.4% | 00.0% | Unchanged | History |
| JBIOJade Biosciences, Inc. | COM | 889,572 | $16.3M | 6.5% | +36,242+4.2% | Added | History |
| KDNYChinook Therapeutics, Inc. | COM | 882,353 | $14.4M | 5.8% | 00.0% | Unchanged | History |
| TYRATyra Biosciences, Inc. | COM | 896,418 | $9.59M | 3.9% | +45,968+5.4% | Added | History |
| TNGXTango Therapeutics, Inc. | COM | 1,254,500 | $9.51M | 3.8% | +1,254,500 | New | History |
| ALPNAlpine Immune Sciences, Inc. | COM | 1,034,222 | $9.28M | 3.7% | −135,990−11.6% | Reduced | History |
| KURAKura Oncology, Inc. | COM | 506,423 | $8.14M | 3.3% | +506,423 | New | History |
| MRUSMerus N.V. | COM | 300,000 | $7.93M | 3.2% | +75,000+33.3% | Added | History |
| AKUSAkouos, Inc. | COM | 1,350,006 | $6.41M | 2.6% | +304,791+29.2% | Added | History |
| DNTHDianthus Therapeutics, Inc. | COM | 2,124,122 | $6.16M | 2.5% | −98,100−4.4% | Reduced | History |
| TRDAEntrada Therapeutics, Inc. | COM | 663,694 | $6.13M | 2.5% | 00.0% | Unchanged | History |
| ZLABZai Lab Ltd | ADR | 95,000 | $4.18M | 1.7% | 00.0% | Unchanged | History |
| PRDSPardes Biosciences, Inc. | COM | 229,100 | $1.65M | 0.7% | +229,100 | New | History |
| ANABAnaptysbio, Inc | COM | 58,515 | $1.45M | 0.6% | +58,515 | New | History |
| ELEVElevation Acquisition Group Inc. | COM | 555,000 | $1.40M | 0.6% | 00.0% | Unchanged | History |